GPR35 and Parkinson disease: Given the critical role of Gpr35 in immune modulation and its expression in the gut epithelium, coupled with the established significance of the gut–brain axis in PD regulation [8], our study provides the first evidence suggesting that Gpr35 could modulate PD progression via microbiota–neuroimmune crosstalk.